Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer
Dominguez-Escrig, J. L.Volume:
10
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-04-0034
Date:
July, 2004
File:
PDF, 681 KB
english, 2004